Madison Asset Management, LLC Grifols Sa Transaction History

Madison Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$10.6 - $13.28 $109,805 - $137,567	10,359 Added 5.62%	194,650 $2.31 Million
Q1 2022 May 12, 2022	BUY	$10.37 - $12.73 $90,447 - $111,031	8,722 Added 4.97%	184,291 $2.15 Million
Q4 2021 Feb 15, 2022	SELL	$10.21 - $15.27 $310,976 - $465,093	-30,458 Reduced 14.78%	175,569 $1.97 Million
Q3 2021 Nov 12, 2021	BUY	$14.07 - $17.3 $487,398 - $599,289	34,641 Added 20.21%	206,027 $3.01 Million
Q2 2021 Aug 09, 2021	BUY	$16.62 - $18.94 $444,817 - $506,910	26,764 Added 18.51%	171,386 $2.97 Million
Q1 2021 May 11, 2021	BUY	$15.15 - $19.78 $23,240 - $30,342	1,534 Added 1.07%	144,622 $2.5 Million
Q4 2020 Feb 12, 2021	BUY	$16.86 - $19.67 $2.41 Million - $2.81 Million	143,088 New	143,088 $2.64 Million

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.31B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Madison Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Madison Asset Management, LLC with notifications on news.